Skip to main content

Table 3 Classification and Baseline Values of Patients

From: Bioinformatic analysis of peripheral blood miRNA of breast cancer patients in relation with anthracycline cardiotoxicity

Group

A (after chemotherapy)

C (before chemotherapy)

P Value

N

20

20

 

Age (median, range)

54 (35–75)

54 (35–75)

NS

Ejection Fractions, EF (median)

48

68

P < 0.001

Hypertension

0

0

NS

Diabetic

0

0

NS

  1. Note:Group A: anthraycline based chemotherapy induced cardiotoxicity; group C:breast cancer patients ejection fraction before starting chemotherapy